ALK status in a series of non-small cell lung cancer (NSCLC) using fluorescence in situ hybridization (FISH)

被引：0
|
作者：
Salido, Marta [1 ]
Galvan, Ana B. [1 ]
Gimeno, Javier [2 ]
-Rivera, Maria Rodriguez [1 ]
Pijuan, Lara [2 ]
Espinet, Blanca [1 ]
Albanell, Joan [3 ]
Arriola, Edurne [3 ]
Serrano, Sergi [2 ]
Sole, Francesc [1 ]
机构：
[1] Hosp del Mar, PSM, IMIM Mol Cytogenet Lab, Dept Pathol, Barcelona, Spain
[2] Hosp del Mar, PSM, IMIM Pathol Dept, Barcelona, Spain
[3] Hosp del Mar, PSM, IMIM Oncol Dept, Barcelona, Spain
来源：
CHROMOSOME RESEARCH | 2011年 / 19卷
关键词：
NSCLC; ALK; EML4; FISH;
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
6.P55
引用
收藏
页码：S162 / S163
页数：2
相关论文
共 50 条
  • [41] β-catenin in non-small cell lung cancer (NSCLC)
    Swinson, DEB
    Lolljee, J
    Edwards, JG
    Jones, JL
    Cox, G
    Richardson, D
    O'Byrne, KJ
    BRITISH JOURNAL OF CANCER, 2002, 86 : S59 - S60
  • [42] Discordance (FISH plus , IHC-) between FISH and IHC Analysis of ALK Status in Advanced Non-Small Cell Lung Cancer (NSCLC): A Unexpected Issue in 7 Cases
    Scattone, Anna
    Petroni, Stella
    Mangia, Anita
    Catino, Annamaria
    Galetta, Domenico
    Schirosi, Laura
    Caldarola, Lucia
    Montagna, Elisabetta Sara
    De Ceglia, Dario
    Perrotti, Pia
    Simone, Giovanni
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S514 - S515
  • [43] Micrometastases in non-small cell lung cancer (NSCLC)
    Passlick, B
    LUNG CANCER, 2001, 34 : S25 - S29
  • [44] Immunotherapy for non-small cell lung cancer (NSCLC)
    Frost, Nikolaj
    Reck, Martin
    INNERE MEDIZIN, 2022, 63 (07): : 709 - 716
  • [45] Genotyping Non-Small Cell Lung Cancer (NSCLC)
    Delia Campos-Parra, Alma
    Cruz-Rico, Graciela
    Arrieta, Oscar
    GACETA MEXICANA DE ONCOLOGIA, 2012, 11 (01): : 35 - 44
  • [46] Treatment of non-small cell lung cancer (NSCLC)
    Zarogoulidis, Konstantinos
    Zarogoulidis, Paul
    Darwiche, Kaid
    Boutsikou, Efimia
    Machairiotis, Nikolaos
    Tsakiridis, Kosmas
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Karapantzos, Ilias
    Huang, Haidong
    Spyratos, Dionysios
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S389 - S396
  • [47] Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization
    Ali, Siraj M.
    Hensing, Thomas
    Schrock, Alexa B.
    Allen, Justin
    Sanford, Eric
    Gowen, Kyle
    Kulkarni, Atul
    He, Jie
    Suh, James H.
    Lipson, Doron
    Elvin, Julia A.
    Yelensky, Roman
    Chalmers, Zachary
    Chmielecki, Juliann
    Peled, Nir
    Klempner, Samuel J.
    Firozvi, Kashif
    Frampton, Garrett M.
    Molina, Julian R.
    Menon, Smitha
    Brahmer, Julie R.
    MacMahon, Heber
    Nowak, Jan
    Ou, Sai-Hong Ignatius
    Zauderer, Marjorie
    Ladanyi, Marc
    Zakowski, Maureen
    Fischbach, Neil
    Ross, Jeffrey S.
    Stephens, Phil J.
    Miller, Vincent A.
    Wakelee, Heather
    Ganesan, Shridar
    Salgia, Ravi
    ONCOLOGIST, 2016, 21 (06): : 762 - 770
  • [48] Eicosanoids in non-small cell lung cancer (NSCLC)
    Johnson, D. H.
    Horn, L.
    Zhao, Z.
    Milne, G.
    Morrow, J.
    Sandler, A.
    Shyr, Y.
    Carbone, D. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
    Christian Manegold
    Petr Zatloukal
    Kurt Krejcy
    Johannes Blatter
    Investigational New Drugs, 2000, 18 : 29 - 42
  • [50] BRCAness in non-small cell lung cancer (NSCLC).
    Waqar, Saiama Naheed
    Devarakonda, Siddhartha H. K.
    Michel, Loren S.
    Maggi, Leonard B.
    Watson, Mark
    Guebert, Kalin
    Carpenter, Danielle
    Sleckman, Barry P.
    Govindan, Ramaswamy
    Morgensztern, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345